CBDual is a pharmaceutical start up company developing products based on cannabidiol (CBD).
First isolated by Israeli scientists in the 1960’s, it was discovered that CBD had great potential as a treatment for a variety of illnesses.
CBD can be derived from either the marijuana or the hemp plant, but hemp is more preferable regarding CBD potency because it naturally has such a high amount of it.
By 2017, the Oral Care Products in the U.S., 8th Edition report projects that retail sales of oral care products will approach $6 billion, reflecting a compound annual growth rate of approximately 4%.
Oral Care Products in the U.S., 8th Edition examines the market for oral care products within the context of broader HBC market trends in new product development and marketing. The major categories covered are ...
(FDA) inspected and Drug Enforcement Agency (DEA) approved facility in Round Rock, Texas, has received DEA approval to manufacture synthetically its pharmaceutical grade Cannabidiol (CBD).
(FDA) has granted orphan drug designation for Epidiolex®, GW’s product candidate that contains plant-derived Cannabidiol (CBD) as its active ingredient, for use in treating children with Lennox-Gastaut syndrome (LGS), a rare and severe form of childhood-onset epilepsy.
CBDual is currently developing two flagship products that contain CBD. Lab research will be conducted in Israel and clinical trials will be handled in the US. CBDual is in the final stages of negotiations between manufactures and distribution partners in North America to develop these flagship products.
Dual Phase Mouthwash - Containing oil emulsifiers that remove bacteria.
Toothpaste - Containing high levels of CBD to strengthen bone & prevent bone loss.
Hemp Toothbrush - The bristles are made of hemp derived fibers. Biodegradable and eco friendly with natural hemp fibers.